Ser2
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.1.1
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser2  -  MAX (rat)

Site Information
______MsDNDDIEV   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 449307

In vivo Characterization
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling ( 2 ) , mass spectrometry ( 1 ) , mutation of modification site ( 2 ) , phosphopeptide mapping ( 2 )
Disease tissue studied:
lymphoma ( 2 ) , Burkitt's lymphoma ( 2 )
Relevant cell line - cell type - tissue:
adipose tissue ( 1 ) , heart ( 1 ) , intestine ( 1 ) , kidney ( 1 ) , liver ( 1 ) , lung ( 1 ) , Manca (B lymphocyte) ( 2 ) , pancreas ( 1 ) , spleen ( 1 ) , thymus ( 1 )

Upstream Regulation
Kinases, in vitro:
CK2A1 (rat) ( 2 )

Downstream Regulation
Effects of modification on MAX:
molecular association, regulation ( 2 )

References 

1

Lundby A, et al. (2012) Quantitative maps of protein phosphorylation sites across 14 different rat organs and tissues. Nat Commun 3, 876
22673903   Curated Info

2

Bousset K, et al. (1993) Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers. Oncogene 8, 3211-20
8247525   Curated Info

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2019 Cell Signaling Technology, Inc.